Titre : Relations interprofessionnelles

Relations interprofessionnelles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Relations interprofessionnelles : Questions médicales les plus fréquentes", "headline": "Relations interprofessionnelles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Relations interprofessionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relations interpersonnelles", "url": "https://questionsmedicales.fr/mesh/D007398", "about": { "@type": "MedicalCondition", "name": "Relations interpersonnelles", "code": { "@type": "MedicalCode", "code": "D007398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Relations médecin-infirmier", "alternateName": "Physician-Nurse Relations", "url": "https://questionsmedicales.fr/mesh/D019555", "about": { "@type": "MedicalCondition", "name": "Relations médecin-infirmier", "code": { "@type": "MedicalCode", "code": "D019555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401.205.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles", "alternateName": "Interprofessional Relations", "code": { "@type": "MedicalCode", "code": "D007400", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fatemeh Keshmiri", "url": "https://questionsmedicales.fr/author/Fatemeh%20Keshmiri", "affiliation": { "@type": "Organization", "name": "Associate Professor, Medical Education Department, Education Development Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran." } }, { "@type": "Person", "name": "Erin Abu-Rish Blakeney", "url": "https://questionsmedicales.fr/author/Erin%20Abu-Rish%20Blakeney", "affiliation": { "@type": "Organization", "name": "School of Nursing, University of Washington , Seattle , WA , USA." } }, { "@type": "Person", "name": "Azam Hosseinpour", "url": "https://questionsmedicales.fr/author/Azam%20Hosseinpour", "affiliation": { "@type": "Organization", "name": "Instructor, Department of Operating Room, School of Allied Medical Sciences, Qom University of Medical Sciences, Qom, Iran." } }, { "@type": "Person", "name": "Katja Krug", "url": "https://questionsmedicales.fr/author/Katja%20Krug", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de." } }, { "@type": "Person", "name": "Michel Wensing", "url": "https://questionsmedicales.fr/author/Michel%20Wensing", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Management Options for Linear Scleroderma (\"En Coup de Sabre\").", "datePublished": "2022-07-22", "url": "https://questionsmedicales.fr/article/35985009", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/DSS.0000000000003539" } }, { "@type": "ScholarlyArticle", "name": "Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.", "datePublished": "2022-07-31", "url": "https://questionsmedicales.fr/article/35921989", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.autrev.2022.103162" } }, { "@type": "ScholarlyArticle", "name": "Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.", "datePublished": "2022-10-11", "url": "https://questionsmedicales.fr/article/36304460", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1004949" } }, { "@type": "ScholarlyArticle", "name": "[Localized scleroderma].", "datePublished": "2024-02-16", "url": "https://questionsmedicales.fr/article/38363312", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00105-024-05297-9" } }, { "@type": "ScholarlyArticle", "name": "Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.", "datePublished": "2023-02-01", "url": "https://questionsmedicales.fr/article/36281773", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/art.42380" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Relations interpersonnelles", "item": "https://questionsmedicales.fr/mesh/D007398" }, { "@type": "ListItem", "position": 4, "name": "Relations interprofessionnelles", "item": "https://questionsmedicales.fr/mesh/D007400" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Relations interprofessionnelles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Relations interprofessionnelles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Relations interprofessionnelles", "description": "Comment évaluer la communication interprofessionnelle ?\nQuels indicateurs mesurent la collaboration interprofessionnelle ?\nQuels outils facilitent le diagnostic interprofessionnel ?\nComment identifier les barrières à la collaboration ?\nQuel rôle joue la culture organisationnelle dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Relations interprofessionnelles", "description": "Quels symptômes indiquent une mauvaise communication ?\nComment reconnaître un manque de collaboration ?\nQuels symptômes affectent la dynamique d'équipe ?\nQuels signes montrent une bonne collaboration ?\nComment les symptômes de stress impactent-ils les relations ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Relations interprofessionnelles", "description": "Comment prévenir les conflits interprofessionnels ?\nQuelles stratégies améliorent la prévention des erreurs ?\nComment sensibiliser à l'importance de la collaboration ?\nQuels outils aident à la prévention des erreurs médicales ?\nComment la prévention impacte-t-elle les soins ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Relations interprofessionnelles", "description": "Comment améliorer les traitements par la collaboration ?\nQuels traitements favorisent la communication ?\nComment évaluer l'efficacité des traitements interprofessionnels ?\nQuels traitements sont adaptés aux équipes interprofessionnelles ?\nComment les traitements peuvent-ils être personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Relations interprofessionnelles", "description": "Quelles complications résultent d'une mauvaise communication ?\nComment les conflits affectent-ils les résultats des soins ?\nQuelles complications peuvent survenir en cas de mauvaise collaboration ?\nComment évaluer l'impact des complications sur les soins ?\nQuelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Relations interprofessionnelles", "description": "Quels facteurs augmentent le risque de conflits ?\nComment le stress influence-t-il les relations interprofessionnelles ?\nQuels facteurs de risque sont liés à la collaboration ?\nComment les différences de statut affectent-elles les relations ?\nQuels facteurs environnementaux influencent la collaboration ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la communication interprofessionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des outils d'évaluation comme des questionnaires et des entretiens." } }, { "@type": "Question", "name": "Quels indicateurs mesurent la collaboration interprofessionnelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent la satisfaction des patients et l'efficacité des soins." } }, { "@type": "Question", "name": "Quels outils facilitent le diagnostic interprofessionnel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des plateformes de partage d'informations et des réunions d'équipe." } }, { "@type": "Question", "name": "Comment identifier les barrières à la collaboration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes et des discussions en groupe pour recueillir des retours d'expérience." } }, { "@type": "Question", "name": "Quel rôle joue la culture organisationnelle dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une culture ouverte favorise la communication et la collaboration entre les professionnels." } }, { "@type": "Question", "name": "Quels symptômes indiquent une mauvaise communication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs médicales fréquentes et des plaintes des patients peuvent en être des signes." } }, { "@type": "Question", "name": "Comment reconnaître un manque de collaboration ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits fréquents et un manque de coordination dans les soins sont des indicateurs." } }, { "@type": "Question", "name": "Quels symptômes affectent la dynamique d'équipe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la frustration et le turnover élevé peuvent affecter la dynamique d'équipe." } }, { "@type": "Question", "name": "Quels signes montrent une bonne collaboration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une communication fluide et des résultats positifs pour les patients sont des signes clés." } }, { "@type": "Question", "name": "Comment les symptômes de stress impactent-ils les relations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut mener à des conflits et à une communication inefficace entre les professionnels." } }, { "@type": "Question", "name": "Comment prévenir les conflits interprofessionnels ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par des formations régulières sur la communication et la gestion des conflits." } }, { "@type": "Question", "name": "Quelles stratégies améliorent la prévention des erreurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles clairs et des revues de cas régulières." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance de la collaboration ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des séminaires et des ateliers sur les bénéfices de la collaboration interprofessionnelle." } }, { "@type": "Question", "name": "Quels outils aident à la prévention des erreurs médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les check-lists et les systèmes de double vérification sont des outils efficaces." } }, { "@type": "Question", "name": "Comment la prévention impacte-t-elle les soins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne prévention réduit les erreurs et améliore la satisfaction des patients." } }, { "@type": "Question", "name": "Comment améliorer les traitements par la collaboration ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "En intégrant des équipes multidisciplinaires pour une approche globale des soins." } }, { "@type": "Question", "name": "Quels traitements favorisent la communication ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des formations en communication et des ateliers de team-building sont bénéfiques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements interprofessionnels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Par des études de cas et des analyses de résultats cliniques post-traitement." } }, { "@type": "Question", "name": "Quels traitements sont adaptés aux équipes interprofessionnelles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements complexes comme la gestion de la douleur nécessitent une approche collaborative." } }, { "@type": "Question", "name": "Comment les traitements peuvent-ils être personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En tenant compte des compétences et des expertises de chaque professionnel de santé." } }, { "@type": "Question", "name": "Quelles complications résultent d'une mauvaise communication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs de traitement et des retards dans les soins peuvent survenir." } }, { "@type": "Question", "name": "Comment les conflits affectent-ils les résultats des soins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits peuvent mener à des soins fragmentés et à une insatisfaction des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de mauvaise collaboration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications médicales et des réadmissions fréquentes peuvent en résulter." } }, { "@type": "Question", "name": "Comment évaluer l'impact des complications sur les soins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses de données sur les résultats cliniques et la satisfaction des patients." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise dynamique peut entraîner un turnover élevé et une baisse de la qualité des soins." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de conflits ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des différences culturelles et des styles de communication variés peuvent augmenter les conflits." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les relations interprofessionnelles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut réduire la communication et augmenter les tensions entre les professionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque sont liés à la collaboration ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un manque de formation et des horaires de travail chargés peuvent nuire à la collaboration." } }, { "@type": "Question", "name": "Comment les différences de statut affectent-elles les relations ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les différences de statut peuvent créer des déséquilibres et des tensions dans l'équipe." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent la collaboration ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement de travail positif et des ressources adéquates favorisent la collaboration." } } ] } ] }

Sources (10000 au total)

Management Options for Linear Scleroderma ("En Coup de Sabre").

En coup de sabre (ECDS) is a form of linear-scleroderma, primarily affecting the face. Despite effectiveness of pharmacological interventions in the management of lesions, sequelae of cutaneous deform... Review the existing surgical tools for the correction of "en coup de sabre" ECDS lesions and facial deformities.... The authors conducted a literature search for reports on surgical interventions for ECDS deformations, in the electronic databases of PubMed, Scopus, and Cochrane Library Databases.... Twenty-six publications reporting 39 patients were found in the literature. The average age of patients was 25 ± 4.7 years. Thirty-one of the patients were females. Six methods were found in the liter... Different surgical and minimally invasive options exist in the armamentarium of clinicians correcting ECDS deformities. Tailoring the method of correction to patient's needs and expectation is crucial...

Scleroderma cardiac crisis: A-life-threatening but reversible complication of systemic sclerosis.

To describe systemic sclerosis (SSc) heart involvement in the ICU.... We retrospectively studied patients with previous diagnosis of SSc admitted to the ICU for acute cardiac dysfunction between 2012 and mid-2021.... 9 female patients were included, mainly with diffuse SSc (n = 7, 78%). Six (67%) had digital ulcers. All but one patient complained about physical cardiac symptoms (n = 8, 89%), 5 (56%) had electrocar... We report an uncommon and specific severe acute life-threatening cardiac dysfunction in SSc patients, which can be reversible but remains associated with a poor long-term prognosis, which can be rever...

Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.

Recent evidence has indicated that alterations in energy metabolism play a critical role in the pathogenesis of fibrotic diseases. Studies have suggested that 'metabolic reprogramming' involving the g... Dermal fibroblasts were isolated from five SSc patients and five healthy donors. Cells were cultured in medium with/without TGF-β1 and with/without ALK5, pan-PIM or ATM kinase inhibitors. Extracellula... Enhanced mitochondrial respiration coupled to ATP production was observed in SSc fibroblasts at the expense of spare respiratory capacity. Although no difference was found in glycolysis when comparing... Our data provide evidence for a novel mechanism(s) by which SSc fibroblasts exhibit altered metabolic programs and highlight changes in respiration and dysregulated mitochondrial morphology and functi...

Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.

Patients with diffuse cutaneous systemic sclerosis (dcSSc) display a complex clinical phenotype. Transcriptional profiling of whole blood or tissue from patients are affected by changes in cellular co... SSc patients were recruited from the Prospective Registry for Early Systemic Sclerosis. Clinical data were collected, as well as peripheral blood for isolation of CMs and NCMs. Age-, sex-, and race-ma... We used an unbiased approach to cluster patients into 3 groups (groups A-C) based on the transcriptional signatures of CMs relative to controls. Each group maintained their characteristic transcriptio... We are the first to show that transcriptional signatures of CMs and NCMs can be used to unbiasedly stratify SSc patients and correlate with disease activity outcome measures....

Association of Race and Risk of Future Scleroderma Renal Crisis at Systemic Sclerosis Diagnosis.

Scleroderma renal crisis (SRC) is a rare and severe manifestation of systemic sclerosis (SSc). Although it is well documented that Black patients with SSc have worse morbidity and mortality than non-B... Using the electronic health record of the US Military Health System, we conducted a comprehensive chart review of each patient with SSc from 2005 to 2016. The final study cohort was comprised of 31 SR... Of 353 patients, 294 had identifiable race (79 Black, 215 non-Black). Thirteen of 79 Black patients (16.5%) versus 16 of 215 (7.4%) non-Black patients developed SRC (P = 0.02). On adjusted analysis, B... Black race was independently associated with a higher risk of future SRC. Further studies are needed to elucidate the mechanisms that underlie this important association....

[Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients].

Pulmonary arterial hypertension (PAH) is a severe, high mortality and progressive disease. Early diagnosis and treatment improves the prognosis. Patients with scleroderma disease presents high risk of... Prospective study of 52 consecutive patients diagnosed of scleroderma in our health area, during 2 years (2018 and 2019). All of them undergo CPET, in addition to the annual systematic screening. Sens... Fifty-two CPET were performed, of which 16 suggested PAH. Resting RHC confirmed PAH in 5 patients and exercise RHC in 7 (diagnostic sensitivity of CPET together with rest and exercise catheterization ... CPET and exercise RHC could detect PAH earlier than established screening in patients with scleroderma disease, allowing early diagnosis....

Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjögren's syndrome?

Sicca complaints are a frequent reason for rheumatologic consultation. Testing for specific antibodies against Ro/SSA and La/SSB antigens and minor salivary gland (MSG) biopsy are among the main tools... Demographic, clinico-pathological, and laboratory data were recorded in 216 consecutive patients with sicca complaints. All study participants were tested for SSc-specific autoantibodies (against CENP... SSc-specific autoantibodies were detected in 41.7% (90/216) patients evaluated (19% at strong, 22.7% at medium titers) without significant differences between anti-Ro/SSA positive and negative groups.... SSc-specific autoantibodies are frequently detected among patients presenting with sicca complaints and at strong but not medium titers are independently associated with MSG biopsy positivity. Taken t...

Periostin overexpression in scleroderma cardiac tissue and its utility as a marker for disease complications.

To evaluate the levels of periostin in patients with systemic sclerosis (SSc) and their association with features of systemic sclerosis.... The levels of periostin were assessed in the serum of 106 SSc patients and 22 healthy controls and by immunofluorescence staining in cardiac tissue from 4 SSc patients and 4 controls. Serum periostin ... Periostin levels were higher in patients with SSc compared to controls and directly correlated to modified Rodnan skin score and echocardiography parameters of left ventricular measurements. Immunoflu... Periostin is elevated in SSc cardiac tissue in vivo and circulating levels of periostin are increased in SSc, correlating with the extent of disease duration, degree of skin fibrosis, and left ventric...